Brief: Cancer Genetics, Inc. Announces $2.0 Million Bought Deal Offering
Oct 28 (Reuters) - Cancer Genetics Inc CGIX.O :
* CANCER GENETICS, INC. ANNOUNCES $2.0 MILLION BOUGHT DEAL
OFFERING
* CANCER GENETICS INC - UNDERWRITER TO PURCHASE ON FIRM
COMMITMENT
BASIS 909,091 SHARES AT $2.20/SHARE
Source text for Eikon: ID:nGNX2lv6wY
Further company coverage: CGIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vyant Bio
See all newsBrief: Vyant Bio Provides Update On Winddown Activities
Brief: Vyant Bio Announces Stockholder Approval Of Plan Of Dissolution
Brief: Vyant Bio Files Form 15 For Voluntary Nasdaq Delisting And SEC Deregistration
Brief: Vyant Bio Announces Filing Of Form 25 For Voluntary Nasdaq Delisting And SEC Deregistration
Brief: Vyant Bio Announces Voluntary Nasdaq Delisting, SEC Deregistration